Efficacy of Management for Rational Use of Antibiotics in Surgical Departments at a Multi-Disciplinary Hospital: Results of a 7-year Pharmacoepidemiological Research


Background. Irrational medicine use including excessive use and abuse of antibiotics remains a crucial problem for the healthcare systems. In this regard, studies examining approaches to improving the clinical use of medicines are highly important. 

Aim: to assess the efficacy rate of management for the rational use of antibiotics in surgical departments of a multi-disciplinary hospital. 

Material and methods. The intervention complex combined the research, educational, and methodological activities: local protocols for perioperative antibiotic prophylaxis (PABP) for various surgical departments were developed; local PABP protocols were discussed with the physicians of specialized surgical departments; official order on implementation of PABP was issued; the list of drug prescriptions for registration of the first pre-operative antibiotic dose was changed; audit and feedback processes were introduced as well as consultations of a clinical pharmacologist were implemented. We assessed the efficacy rate of the interventions basing on the changes in consumption of antibiotics (both quantitatively and qualitatively) at surgical departments of a hospital using ATC/DDD methodology. Comparison of the studied outcomes was performed before and after the intervention implementation and between the departments (vascular and abdominal surgery). The consumption of antibacterial agents (ATCJ01) was measured as a number of defined daily doses (DDD) per 100 bed-days (DDD/100 bed-days, indicator recommended by the World Health Organization, WHO) and DDD per 100 treated patients (DDD/100 treated patients). 

Results. From 2006 to 2012, a decrease in antibacterial consumption in surgical departments by 188 DDD/100 treated patients was observed. We obtained the opposite results when using an indicator of DDD/100 bed-days (increase by 2.5 DDD/100 bed-days) which could be explained by the dependence on indices of overall hospital work and its changes during the examined period. Observed changes in antibacterial consumption varied in different surgical departments. The most pronounced positive changes were noted in the department of vascular surgery: decrease in total antibacterial consumption by 298 DDD/100 treated patients, decrease in the use of cephalosporins of the III generation from 141 to 38 DDD/100 treated patients. These positive changes were accompanied by the same (low) level of consumption/use of reserve antibiotics. In the department of abdominal surgery, there was no decrease in total antibiotic consumption, as well as in consumption of broad-spectrum cephalosporins of the III generation and fluoroquinolones, and we observed an increase in the use of reserve antibiotics (carbapenems) during the study period. Positive changes in antibiotic consumption were associated with the positive attitude of the manager/head of the department towards interventions: we observed the most pronounced decrease in antibiotic consumption straight after the publication of the administrative order on perioperative antibacterial prophylaxis. 

Conclusion. The combination of scientific, educational, and methodological interventions is effective for improving antibiotic application. The study results provide the rationale for analyzing the drug consumption using the DDD/100 treated patients measure in addition to the WHO-recommended indicator of DDD/100 bed-days which depends on overall hospital performance.

About the authors

A. A. Korableva

Kazan Federal University

Author for correspondence.
Email: anna-korableva@yandex.ru
ORCID iD: 0000-0001-6322-4659

Кандидат медицинских наук, доцент кафедры фундаментальной и клинической фармакологии ИФМиБ.

Адрес: 420008, Казань, ул. Кремлевская, д. 18.

SPIN-код: 3858-4733

Russian Federation

E. V. Yudina

Kazan Federal University

Email: ekaterina.v.yudina@mail.ru
ORCID iD: 0000-0002-1586-8000

Кандидат медицинских наук, доцент кафедры фундаментальной и клинической фармакологии ИФМиБ.

Адрес: 420008, Казань, ул. Кремлевская, д. 18

SPIN-код: 3053-1161

Russian Federation

L. E. Ziganshina

Kazan Federal University

Email: lezign@gmail.com
ORCID iD: 0000-0003-1999-0705

Доктор медицинских наук, профессор, заведующая кафедрой фундаментальной и клинической фармакологии ИФМиБ.

Адрес: 420008, Казань, ул. Кремлевская, д. 18.

SPIN-код: 6061-7223

Russian Federation


  1. Mahmood A, Elnour AA, Ali AA, et al. Evaluation of rational use of medicines (RUM) in four government hospitals in UAE. Saudi Pharm J. 2016;24(2):189−196. doi: 10.1016/j.jsps.2015.03.003.
  2. Mao W, Vu H, Xie Z, et al. Systematic review on irrational use of medicines in China and Vietnam. PLoS ONE. 2015;10(3):e0117710. doi: 10.1371/journal.pone.0117710.
  3. Лопухова В.А., Тарасенко И.В. Структура потребления лекарственных средств при терапии хронических респираторных заболеваний у взрослых // Сибирское медицинское обозрение. ― 2012. ― №4 ― С. 32–34. [Lopukhova VA, Tarasenko IV. Struktura potrebleniya lekarstvennykh sredstv pri terapii khronicheskikh respiratornykh zabolevanii u vzroslykh. Sibirskoe meditsinskoe obozrenie. 2012;(4):32–34. (In Russ).]
  4. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy Plan. 1999;14(2):89−102. doi: 10.1093/heapol/14.2.89.
  5. Sketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol. 2009;16(1):e103−125.
  6. Ostini R, Hegney D, Jackson C, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43(3):502–513. doi: 10.1345/aph.1L488.
  7. Elouafkaoui P, Young L, Newlands R, et al. An audit and feedback intervention for reducing antibiotic prescribing in general dental practice: the rapid cluster randomised controlled trial. PLoS Med. 2016;13(8):e1002115. doi: 10.1371/journal.pmed.1002115.
  8. Wise R, Hart T, Cars O, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998;317(7159):609–610. doi: 10.1136/bmj.317.7159.609.
  9. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12 Suppl):S122−S129. doi: 10.1038/nm1145.
  10. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;(4):CD003539. doi: 10.1002/14651858.CD003539.pub2.
  11. Evans D, Haines A, editors. Implementing evidence-based changes in healthcare. Oxford: Radcliffe Publishing; 2000. 316 p.
  12. who.int [интернет]. ВОЗ. Рациональное использование лекарств. [WHO. The pursuit of responsible use of medicines: sharing and learning from country experiences. (In Russ).] Доступно по: http://www.who.int/medicines/areas/rational_use/ru/. Ссылка активна на 07.06.2016.
  13. whocc.no [Internet]. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2017 [updated 2016 Dec 19; cited 2016 Dec 21]. Available from: https://www.whocc.no/atc_ddd_index/.
  14. Александрова Э.Г., Евченко О.В., Зиганшина Л.Е. Использование антибактериальных средств в медицинских учреждениях Республики Татарстан в 2007 г. и 2010 г. / II Международная научно-практическая конференция студентов и молодых ученых «Молодежь и наука: модернизация и инновационное развитие страны». Октябрь 26−27, 2012; Пенза. — Пенза: Изд. ФГБОУ ВПО Пензенский госуниверситет; 2012. С. 58−62. [Aleksandrova EG, Evchenko OV, Ziganshina LE. Ispol’zovanie antibakterial’nykh sredstv v meditsinskikh uchrezhdeniyakh Respubliki Tatarstan v 2007 i 2010 g. (Conference proceedigs) II Mezhdunarodnaya nauchno-prakticheskaya konferentsiya studentov i molodykh uchenykh «Molodezh’ i nauka: modernizatsiya i innovatsionnoe razvitie strany»; 2012 oct 26–27; Penza. Penza: Izd. FGBOU VPO Penzenskii gosuniversitet; 2012. p. 58−62. (In Russ).] Доступно по: http://repository.kpfu.ru/?p_id=45092. Ссылка активна на 12.12.2016.
  15. Александрова Э.Г. Использование цефтриаксона учреждениями здравоохранения Республики Татарстан с 2005 по 2010 гг. / IV Международная конференция по клинической фармакологии и фармакотерапии «Актуальные вопросы (к 40-летию Клинической фармакологии в РФ) / Под ред. В.Г. Кукеса. Сентябрь 8−10, 2014; М. — С. 6—7. [Aleksandrova EG. Ispol’zovanie tseftriaksona uchrezhdeniyami zdravookhraneniya Respubliki Tatarstan s 2005 po 2010 gg. (Conference proceedigs) Mezhdunarodnaya konferentsii konferentsiya po klinicheskoi farmakologii i farmakoterapii «Aktual’nye voprosy (k 40-letiyu Klinicheskoi farmakologii v RF). Ed by Kukes V.G. 2014 sep 8−10; Moscow. Moscow: Izd-vo ANO Mezhdunarodnaya assotsiatsiya klinicheskikh farmakologov i farmatsevtov; 2014. p. 6–7. (In Russ).]
  16. Aleksandrova E, Ziganshina L. Six-year analysis of cephalosporin use in public health facilities of Tatarstan. In: The Netherlands overview abstracts. Utrecht WHO Winter Meeting; 2014 Jan 7−8; The Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht, Netherlands. Utrecht; 2014. p. 32.
  17. Stewart A, Eyers PS, Earnshaw JJ. Prevention of infection in arterial reconstruction. Cochrane Database Syst Rev. 2006;(3):CD003073. doi: 10.1002/14651858.CD003073.pub2.
  18. Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev. 2012;(2):CD003769. doi: 10.1002/14651858.CD003769.pub4.
  19. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;(3):CD001439. doi: 10.1002/14651858.CD001439.pub2.
  20. Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;(5):CD002941. doi: 10.1002/14651858.CD002941.pub3.
  21. Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, et al. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro Surveill. 2011;16(40):pii19983.
  22. Urbánek K, Kolář M, Lovečková Y, et al. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther. 2007;32(4):403–408. doi: 10.1111/j.1365-2710.2007.00836.x.
  23. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010;14(3):R113. doi: 10.1186/cc9062.
  24. ecdc.europa.eu [Internet]. European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union. Stockholm: ECDC; 2014 [cited 2016 Nov 9]. Available from: http://ecdc.europa.eu/en/eaad/Documents/antibiotics-consumption-EU-data-2014.pdf.
  25. Filius PM, Liem TB, van der Linden PD, et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005;55(5):805–808. doi: 10.1093/jac/dki093.

Supplementary files

There are no supplementary files to display.

Comments on this article

Copyright (c) 2017 "Paediatrician" Publishers LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies